AT
RMD icon

Avalon Trust’s ResMed RMD Stock Holding History

Avalon Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Sell
87,722
-7,295
-8% -$1.51M 1.05% 28
2026
Q1 		$21.3M Buy
95,017
+2,553
+3% +$636K 1.47% 20
2025
Q4 		$22.3M Buy
92,464
+834
+0.9% +$213K 1.44% 17
2025
Q3 		$25.1M Sell
91,630
-578
-0.6% -$158K 1.63% 16
2025
Q2 		$23.8M Sell
92,208
-3,577
-4% -$853K 1.74% 14
2025
Q1 		$21.4M Buy
95,785
+1,685
+2% +$393K 1.71% 17
2024
Q4 		$21.5M Sell
94,100
-465
-0.5% -$112K 1.53% 18
2024
Q3 		$23.1M Sell
94,565
-475
-0.5% -$106K 1.71% 20
2024
Q2 		$18.2M Buy
95,040
+350
+0.4% +$71K 1.44% 23
2024
Q1 		$18.8M Buy
+94,690
New +$17.4M 1.54% 23

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Avalon Trust's RMD Position: Q2 2026 in Review

Avalon Trust reduced its ResMed (RMD) stake by 7.7% in Q2 2026, selling an estimated $1.51M and leaving 87,722 shares worth $17.1M. The position accounts for 1.05% of the portfolio, ranked #28.

Avalon Trust first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $25.1M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Avalon Trust held 87,722 shares of ResMed worth $17.1M as of Q2 2026.
  • Avalon Trust sold 7,295 ResMed shares in Q2 2026, an estimated $1.51M.
  • ResMed made up 1.05% of Avalon Trust's portfolio in Q2 2026, its #28 holding.
  • Avalon Trust first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Avalon Trust's ResMed position peaked at $25.1M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.